Combining the 31-gene expression profile test for cutaneous melanoma with the American Joint Committee on Cancer staging identifies the highest-risk patients with stage I-II disease. J of Skin [Internet]. 2023 Jul. 17 [cited 2025 Oct. 14];7(4):s223. Available from: https://skin.dermsquared.com/skin/article/view/2198